← Back to Vaccine Database

Live recombinant Newcastle Disease Virus (rNDV) vector vaccine

Inactivated vaccine · VDDBV0460

Target & Classification

SARS-CoV-2SARS-CoV-2
Inactivated vaccine
COVID-19
Phase 2

Clinical Development

Phase 1
Phase 2
Phase 3
Approved

Clinical Trials2

NCT IDPhaseDisease / Condition
NCT04871737 Phase 1COVID-19
NCT05205746 Phase 2COVID-19